NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
The NIDA R25 program supports education for clinical researchers and clinicians in substance use and disorder to meet biomedical and clinical research needs.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: March 11, 2025 | August 12, 2025 | November 12, 2025 | March 11, 2026 | August 12, 2026 | August 13, 2026 (NOFO Expiration)
Funding Amounts: Up to $350,000 in direct costs per year for up to 5 years; total program funding estimated at $350,000.
Summary: Supports research education programs to enhance the training of clinical researchers and clinicians in substance use and substance use disorder research; clinical trials are not allowed.
Key Information: Applications must focus on both skills development and research experiences; non-research clinical training is not supported.
Description
This NIH Research Education Program (R25), administered by the National Institute on Drug Abuse (NIDA), is designed to support educational activities that complement and enhance the training of a workforce capable of addressing the nation’s biomedical, behavioral, and clinical research needs in substance use and substance use disorders (SUD). The program specifically targets clinicians, clinical researchers, and those in training for such careers, aiming to increase their knowledge and active participation in SUD research.
The R25 mechanism under this NOFO does not allow for clinical trials. Instead, it supports a combination of courses for skills development and mentored research experiences, with a primary emphasis on research experiences. Programs should facilitate the transition of scholars to their next career stage and may include activities such as laboratory rotations, project-based research, collaborative networks, presentations at conferences, and career development workshops.
The overarching goal is to ensure a pipeline of highly trained clinical scientists to address substance use crises, reduce SUD burden, and enhance research capacity, especially among underrepresented and underserved populations.
